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Explanations proposed for the mechanism of this vomiting fall into two groups, namely, a local effect upon the gastro-intestinal tract and a central effect upon the vomiting center. The latter view is supported by the work of Marshall and Long,' who have observed that vomiting is produced both in dogs and man when sodium sulfapyridine is given intravenously. That this explanation may not be entirely correct, however, has been suggested by Haviland and Blake,' who found that the sulfapyridine concentration in vomitus of patients receiving sulfapyridine by a parenteral route-only may be considerably higher than that in the blood.
In addition, we have observed that sulfapyridine is excreted into the stomach of the dog with surprising rapidity following the intravenous injection of sodium sulfapyridine. In Table 1 are summarized the results of ten experiments in which a 5 per cent solution of sodium sulfapyridine was injected intravenously into dogs until vomiting was produced. As soon as possible after the act of vomiting, a specimen of blood was taken from the dog. In both this and the vomitus the concentration of non-acetylated sulfapyridine was determined by the method of Marshall and Litchfield.4 The time at which emesis occurred after beginning the injection of sulfapyridine is also recorded. The that in the blood. These observations, then, would leave open the question as to whether the excretion of sulfapyridine into the gastric juice might not play some part in the mechanism of nausea and vomiting.
We have, therefore, systematically studied the problem in the dog, which is an excellent animal to use in an experimental study of this nature, since it exhibits definite signs of nausea, as evidenced by salivation, licking, chewing, and apprehension, and vomits readily and with satisfactory consistency under treatment with sulfapyridine. Experiments dealing with (1) the relation between blood concentration of sulfapyridine and emesis in normal dogs, (2) the effect of total gastrectomy and complete gastro-intestinal evisceration on the emetic action of sulfapyridine, and (3) the response of the vomiting center to the direct application of sulfapyridine, are. recorded in this paper.
In these studies dogs were selected which consistently vomited when given sulfapyridine, since one may occasionally find dogs in which the emetic action of the drugs is absent or not manifest until toxic cerebral symptoms are produced. In Table 2 are summarized the results of 29 such experiments upon 16 normal and intact dogs. Of these 16 dogs, 13 vomited at a sulfapyridine concentration in the blood of from 17 to 36.5 mg. per cent. The remaining three dogs, Nos. 13, 14, and 17, did not vomit before symptoms of central nervous system intoxication became evident, at which time the injections were terminated. The sulfapyridine blood concentration in these three dogs ranged from 33 to 41 mg. per cent at this time.
Of the 13 dogs that vomited, two (Nos. 6 system became manifest. It should be mentioned, perhaps, that both these dogs and the other three which failed to vomit, appeared to be of nervous temperament and rather high-strung. Experiments carried out on one dog (No. 1) revealed that the onset of vomiting and its relation to blood concentration of sulfapyridine was not materially changed by the prior instillation into the stomach of a solution or suspension containing up to as much as 1 per cent of sulfapyridine in water. These experiments are presented in Table 2 .
Experiments on gastrectomized and eviscerated dogs In order to exdude the possible local effect of sulfapyridine on the stomach as part of the mechan'ism involved in the vomiting caused by this drug, five similar experiments were carried out on three gastrectomized dogs.
These dogs were subjected to total gastrectomy, and, 3 to 12 weeks later, intravenous injection of sodium sulfapyridine was carried out by the same procedure as that used in the normal dogs. All three dogs vomited within the range of blood concentrations found to cause emesis in normal dogs. The data are shown in Table 3 . In these experiments, two of the five dogs did not vomit. One dog (No. 12) fell into shock during operation and remained so depressed after operation that failure to vomit is not surprising. The other dog (No. 9) had not been tested for vomiting with sulfapyridine before operation and it seems possible that it would fall iInto the small group of dogs that fail to vomit with the drug prior to the onset of convulsions. It may also be observed that there is no essential difference in the blood concentration of sulfapyridine at the time of emesis in the dogs either prior to or after evisceration.
Results of these experiments, then, would certainly indicate that vomiting caused by sulfapyridine is not dependent upon the presence of sulfapyridine in the gastro-intestinal tract, whether ingested or excreted into the stomach.
Experiments on the vomiting center
A study of the possible direct action of sulfapyridine upon the vomiting center was then undertaken. In 1891 Thumas6 described an area situated in the floor of the fourth ventricle in the region of the dorsal nucleus of the vagus nerve which he called the vomiting center. More specifically, this is a physiological area in the midline of the floor of the fourth ventricle measuring about 5 mm. in length and 2 mm. in width and extending to a point about 2 mm. posterior to the calamus scriptorius. He found that destruction of this area caused inhibition of vomiting and that the local application of minute quantities of apomorphine to this point caused prompt emesis in dogs. This center may be exposed with moderate difficulty in the living dog in a two-stage operation as originally described by Hatcher and Weiss.2
Our procedure was, briefly, as follows: A dog of suitable size and disposition was trained for several weeks to lie quietly in the prone position with head extended between the fore legs. Under sterile precautions and deep nembutal anesthesia, an incision in the midline was made extending from the nuchal crest to the level of the third cervical vertebra and carried down to the skull. Following initial trephine, the bone over the inferior portion of the cerebellum was now rongeured away so that an opening of from 1.5 to 2 cm. was made. The wound was then closed with interrupted silk sutures, taking special precautions to secure perfect hemostasis.
Twenty-four hours later with the dog in prone position, the wound was opened, under local novocaine anesthesia, exposing the dura. This and the arachnoid were opened exposing the cerebellum which could be gently lifted up, thus bringing into view the floor of the fourth ventride.
Various concentrations of sulfapyridine in normal saline, ranging from 10 to 100 mg. per cent, were now dropped in turn from a micro-pipette on to the vomiting center. Following this, solutions of apomorphine in normal saline, beginning with a concentration as low as 0.0001 mg. of apomorphine per 1.0 cc. of solution were applied to the vomiting center in a similar manner. When emesis had been produced, the operative wound was closed and sodium sulfapyridine was then administered intravenously to the point of vomiting.
The protocol of a typical experiment is given below: The results of three such experiments are summarized in Table 5 . It may be observed that none of these dogs vomited with the local application of sulfapyridine. Two of the dogs vomited following the local application of apomorphine in quantities of 0.0005 (0.0002 and 0.0003) and 0.007 mg., respectively. The failure of the remaining dog to vomit we believe to be due to a web of fibrin over the medulla which was impossible to remove. All three dogs vomited promptly upon the intravenous administration of sodium sulfapyridine.
These experiments would suggest that sulfapyridine vomiting is Inot due to a direct action upon the vomiting center. This statement, of course, assumes that sulfapyridine will penetrate to the vomiting center as rapidly as apomorphine, but direct proof of this is lacking. Discussion The present explanation is that the act of vomiting, in general, is dependent upon three factors: (1) coordinated actions of the muscles of the stomach, esophagus, and abdominal wall; (2) a center' in the medulla, which discharges impulses along efferent fibers in the phrenic, sympathetic, and cranial nerves; and (3) the stimulation of this vomiting center by afferent impulses arising in any of the viscera or even in other cerebral centers. This vomiting center may also be stimulated directly by certain agents, carried to it in the blood stream, such as apomorphine, emetine, and picrotoxin.
In regard to the mechanism of vomiting due specifically to sulfa- pyridine, it would appear, with the experimental evidence offered above, that it is dependent upon an indirect stimulation of the vomiting center, mediated either through reflexes arising from some organ other than the gastro-intestinal tract or through action of the drug on other cerebral centers. This interpretation obviously depends upon the assumption that sulfapyridine directly applied to the vomiting center actually penetrates as does apomorphine.
The fact that both man and dog vomit following the intravenous administration of the drug is not sufficient evidence for assuming that sulfapyridine acts directly upon the vomiting center.
The exact site of origin of the reflex stimulation by sulfapyridine on the vomiting center is not clear at the present time and further investigation of this problem is in progress.
Summary and coiwlusions 1. Following the intravenous injection of a 5 per cent solution of sodium sulfapyridine, dogs were found to vomit at a sulfapyridine concentration in the blood of from 17 to 36.5 mg. per cent. Occasionally, dogs were found that did not vomit, but exhibited signs of central nervous system intoxication when the blood sulfapyridine reached a sufficiently high level.
2. Sulfapyridine is readily excreted into the stomach after the intravenous injection of a S per cent solution of sodium sulfapyridine.
3. Removal of the stomach, and even of the entire gastrointestinal tract including the spleen and the greater part of the pancreas, does not inhibit the act of vomiting when sodium sulfapyridine is given intravenously in dogs. 4 . Direct application of sulfapyridine, in a concentration as high as 100 mg. per cent, to the vomiting center does not cause vomiting, whereas similar application of apomorphine to the vomiting center does cause emesis.
The above facts indicate that sulfapyridine vomiting in dogs
is not due either to local action in the stomach or to direct action upon the vomiting center. They further suggest that the vomiting is mediated through a reflex stimulation of the vomiting center, which certainly is not exclusively from the gastro-intestinal tract but may arise from some other site or sites.
